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Abstract 
 
Human whole saliva contains peroxidases (human peroxidase and myeloperoxidase) which are part of the innate host 
defence mechanism in oral cavity. The primary function is to catalyse the oxidation of thyocyanate, in the presence of 
hydrogen peroxidase, that resulting in the end product of wide antimicrobial activity. Patient with HIV/AIDS is often 
decreased in salivary flow rate, and this condition may also change the salivary composisition. These changes are 
contributed in oral lesions of HIV/AIDS patients. The aim of this study was to evaluate the salivary peroxidase activities 
of HIV/AIDS patients. The study involved 98 patients with HIV/AIDS of whom 55 were men and 43 were women. 
Unstimulated whole saliva was collected and all the patients received a complete oral examination.  The saliva samples 
were analysed with Bradford assay (with Bradford reagent) and salivary peroxidase measurement with microplate reader 
and read at 450 nm wave length. The results showed that the mean concentration of total salivary protein and peroxidase 
in this study population was 1169µg/ml (SD±186.1) and 6.101unit/mg Protein (SD±1.26) respectively. It showed a 
tendency that the lower the CD4 level, the higher the total protein concentration as well as salivary peroxidase activity, 
however the difference was not statistically significant (p>0.05).  Patients’ data on age, sex, salivary flow rate and pH did 
not significantly influencing the total salivary protein concentration as well as the peroxidase activity (p>0.05). This study 
showed that salivary peroxidase activity have a correlation with the total salivary protein concentration. There was a 
tendency of higher total protein concentration and salivary peroxidase activity found in patients with lower CD4 counts 
but in those with more acidic saliva. In conclusion, salivary peroxidase activity have a correlation with the total salivary  
protein concentration in HIV/AIDS patients. 
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INTRODUCTION 
 
   HIV/AIDS has become serious global health pro-
blems. The prevalence and incidence of HIV/AIDS 
patients were increased all the time. 1-3 Indonesia is 
one of the fastest epidemic growth in the world.4 
Oral health is an essensial factor that has correlation 
with systemic health, including in patient with 
HIV/AIDS infection. Good nutritions are needed to 
maintain the stability or increasing the immune 
conditions, thus proper oral health is a necessity. 
The oral manifestations of HIV/AIDS patients are 
also the important issues that must be overcome to 
improve the quality of life of patients. Based on the 
research,  70-90 %  HIV/AIDS  patients, had at least  
 
 
one oral manifestation during their course of life. 5, 6 
   Bacteria, is one of the etiologies of oral oppor-
tunistic infection in HIV/AIDS patients. The chang-
es of saliva function and composition in HIV/AIDS 
infected patients are contributing factors to the oral 
opportunistic infection. 7 
   Saliva is an essential oral fluid that is taken for 
granted to maintain oral homeostasis. 8-10 Various 
salivary enzymes have antibacterial and antifungal 
function. The enzymes were innate immune system 
in oral cavity. Salivary peroxidase is one of the en-
zymes that has antibacterial function. 9, 11  The aims 
of this research were to evaluate and analyse the 
relationship between salivary lactoperoxidase ac-
tivety  versus   CD4+  count  in HIV/AIDS  patients,  
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and their correlations with contributing factors.  
 
MATERIALS AND METHODS 
 
   The cross sectional study was composed of 98 
HIV/AIDS patients; 55 men and 43 women, in 
accordance with inclusion criteria, who came to 
POKDISUS AIDS RSCM from January-February 
2011 (consecutive study). Diagnosis of HIV/AIDS 
was determined by the internist in RSCM. Only pa-
tients without antifungal therapy were included in 
this study. All participants provided informed con-
sent to the research protocol that had been reviewed 
and approved by the Ethic Committee of Faculty of 
Dentistry Universitas Indonesia. The participants 
age range from 20 to over 50 years. Patient records 
were used to obtain CD4+ count. Unstimulated 
whole saliva was collected and all the patients re-
ceived a complete oral examination.   
   Unstimulated whole saliva samples were collected 
from each subject, according to spitting method. 
Saliva collection time was 9.00-13.00. Participants 
were asked to fast for 1 h before the test. Participants 
were asked to lean the head forward, kept the eyes 
open, minimized the movement of the tongue and 
the lips. Saliva was collected for 5 minutes (spitting 
every minute in 5 minutes) into the tube through the 
tunnel. Salivary flow rate and pH were analyzed, 
using universal indicator, and immediately stored in 
portable freezer. In the laboratory, this saliva was 
centrifuged with 1000 rpm, 40C in 5 minutes. The 
supernatant was frozen and stored in a -800C until 
protein and enzyme lactoperoxidase analized. The 
saliva samples were analysed with Bradford assay 
(with Bradford reagent: Super-Bradford Protein As-
say Kit CWBIO version: 03092009; technical ma-
nual no: M0013), and read the absorbance by micro-
plate reader at 640nm wave length. Supernatant was 
taken 50 µl, added with guaiacol 50 µl, buffer fosfat 
100 µl, and H2O2 2 µl, mixed in microwell plate. 
Salivary peroxidase absorbance was read with 
microplate reader at 450 nm wave length. 
   Statistical analysis using GraphPad Prism 5 soft-
ware to compare the results with other parameter 
such as age, sex, smoking habits, CD4 counts, oral 
hygiene status, salivary flow rate, pH were perfor-
med using Student t-test and One-way ANOVA 
continued with Newman-Keuls Multiple Compari-
son Test to observe correlation between parameters 
tested with P value <0.05 for result set for the results 
to be statistically significant.  
 
RESULTS 
 
   The  study  involved  104 patients with HIV/AIDS  
of whom 57 were men and 47 were women. Tabel 1 
described the frequency characteristic distribution in 
HIV/AIDS patients based on gender, age, risk fac-
tors of transmission, and CD4+ counts. This demo-
graphic data was obtained from anamnesis and con-
firmed the patient’s medical record books, which 
was then recorded on research examination sheet. 
The CD4+count was based on the last conducted 
and record in the medical record books. 
 
Tabel 1.  Characteristic of HIV/AIDS sample based on 
gender, age, risk factor of transmission and 
CD4+ counts  (N=98) 
 
Characteristic of sampel N % 
Gender 
  Men 
  Women 
Age(year) 
  20-30 
  31-40 
  41-50 
  >50 
 
Risk factors of tranmission 
  IVDU 
  Homosexual 
  Heterosexual 
  IVDU and homoxual 
  IVDU heterosexual 
  Others 
 
CD4+ (sel/ µl)count 
  <200 
  201-500 
  >500 
 
Salivary flow rate 
  < 0,19  
  >0,2 
 
pH Saliva 
  Highly acidic 
  Moderate acidic 
  Healthy saliva 
 
55 
43 
 
25 
65 
4 
4 
 
 
22 
3 
60 
0 
7 
6 
 
 
22 
59 
17 
 
 
28 
70 
 
 
12 
46 
40 
 
56 
44 
 
25.5 
66.3 
4.1 
4.1 
 
 
22.4 
3.06 
61.2 
0 
 
 
 
 
22.4 
60.2 
17.4 
 
 
28.6 
71.4 
 
 
12.3 
46.9 
40.8 
 
   Based on gender, appears the tendency of lacto-
peroxidase activity in 43(43.88%) female (6.23 
unit/mg protein) slightly higher compared with 55 
(56.12%) men (5.99 unit/mg protein), but this was 
not statistically significant (Tabel 2). 
 
Table 2. Relationship between gender and mean salivary 
protein concentration & lactoperoxidase  
 
Gender 
Mean salivary  
Protein concen-
tration (µg/ml) 
Mean sali-
vary lacto-
peroxidase 
p 
 
Men 
 
1168.34±185.25 
 
5.99±1.25  
> 0,05 
Women 1169.80±189.41 6.23±1.28 
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By age, the concentration of salivary concentration 
and lactoperoxidase activity also was not signi-
ficantly different (Tabel 3). 
 
Table 3. Mean salivary protein concentration based on age 
 
Age 
(year) 
Protein 
Concentration 
(ug/ml) 
SD N p 
20-30 1134.951 181.42 25 
> 0,005 31-40 1189.56 190.04 65 
41-50 1086.81 174.52 4 
>51 1062.50 38.01 4 
 
   CD4+ count indicates the immunosupression level 
of HIV/AIDS patients. The salivary protein con-
centration tended to be lower than the salivary 
concentration in patients with lower CD4+ count. 
This trend was not statistically significant. The 
clinical examination of HIV/AIDS patients showed 
the oral hygiene were not good, with focus infec-
tions(radices, deep caries, periodontal disease) and 
smoking habit were also noted. This indicated the 
existence of the oral mucosa defence system in-
creases with the existence of both physical and 
chemical exposure from cigarette. Kanehira T stated 
that the level of salivary thiocyanat (SCN-) in smo-
kers about twice more than in non smokers.  
 
Table 4. Salivary protein concentration based on CD4+ 
count classification (ug/ml) 
 
CD4+ count 
classifycations 
(cell/µl) 
Salivary protein 
(ug/ml) 
 
N 
Mean SD 
CD4 (<200) 1191.829 218.50 22 
CD4 (201-500) 1178.383 174.63 59 
CD4 (>500) 1106.793 177.88 17 
 
   The mean of salivary peroxidase activity com-
pared with CD4+count showed the declining trend 
of peroxidase activity in samples with CD4+ >500 
cell/µl. Samples with CD4+<200cell/ µl had a 
higher tendency of peroxidase activity. There was 
no significant relationship between CD4+ level with 
peroxidase activity. 
 
Table 5. Mean salivary peroxidase activity based on 
CD4+ count classification(cell/ µl)  
 
CD4+countclassi-
fication (cell/ µl) 
Salivary peroxidase N 
Mean SD 
CD4+ (<200) 6.22 1.32 22 
CD4+ (201-500) 6.15 1.37 59 
CD4+ (>500) 5.77 0.70 17 
 
   Salivary protein concentration was higher in sali-
vary flow <0.2 ml/minute, with an average was 
1219.09 ug/ml. Compared with Salivary flow rate 
>0.2ml/minute (70 samples), the average was 
1148.78 ug/ml. However this difference was not 
statistically significant. The relationship between 
salivary flow rate and peroxidase activity, described 
the tendency of increasing peroxidase activity in 
salivary flow rate <0.2 ml/minute, this difference 
was not statistically significant (Table 6). 
 
Table 6. Comparition between salivary flow rate and 
peroxidase activity 
 
Salivary flow 
rate 
(ml/minute) 
Salivary Peroxidase 
activity 
(unit/mg protein) 
SD N 
<0.2ml/menit 6.13 1.46 28 
>0.2ml/menit 6.09 1.19 70 
 
   Salivary pH was measured in this research. There 
are (12.3%) salivary samples with highly acidic, 
(46.9%), sample moderate acid saliva and remaining 
(40.8%) health salivary sample. In comparison bet-
ween acidity saliva and salivary protein concentra-
tion showed there was increasing salivary protein 
concentration in acidic saliva compared with healthy 
saliva, however this trend was not statistically signi-
ficant. 
 
Tabel 7. Relationship between salivary pH and protein 
concentration 
 
Salivary pH 
classification 
Mean Salivary 
Protein 
Concentration 
SD N 
High acid 1171.13 178.3 12 
Moderate acid 1170.48 189.15 46 
Healthty saliva 1166.62 189.15 40 
 
   When compared pH saliva in HIV/AIDS patients 
with salivary peroxidase activity, acidic salivary 
sample had higher salivary peroxidase activity than 
normal salivary sample. This trend was not statistic-
cally significant.  
 
Table 8. Relationship between salivary pH with peroxi-
dase activity 
 
Salivary pH 
classification 
Mean Salivary Protein 
Concentration 
(unit/mg protein) 
SD N 
High acid 
 
6.09 1.92 12 
Moderate acid 
 
 
6.16 1.26 46 
Healthy acid 
 
6.03 1.04 40 
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DISCUSSION 
 
   Salivary peroxidase system (SPS) is a non specific 
immune system in saliva, consisting of peroxidase 
and thiocyanat ion (SCN-) and hydrogen peroxide 
(H2O2). Peroxidase and thiocyanat are normal com-
ponent contained in saliva, while hydrogen peroxi-
dase derived from micro organism in oral cavity. 12 
Oral bacteria produced H2O2 during anaerobic gly-
colysis. At sufficient concentrations, H2O2 is cyto-
toxic to mammalian cell lines, including human 
epithelial cells and gingival fibroblasts. It has been 
previously suggested that one of the important roles 
of human peroxidases is to detoxify H2O2, to prevent 
oral mucosa damage. 13 SPS has effect that can in-
hibit the growth of micro organism. 14 Peroxidase is 
an oxidation catalyst reaction of thiocyanat ion with 
hydrogen peroxidase which would be hypothio-
cyanat acid (HOSCN) or hypothiocyanat anion    
(OSCN-), which is antibacterial. 9 
 
SCN-     +   H2O2               peroxidase           OSCN-   +   H2O 
 
   The H2O2 was produced by microorganisms was 
used in the oxidation of SCN- to produced OSCN-
(antibacterial agent) which in turn reduced the 
amount of micro organism. The decreasing in the 
number of microorganisms decreased the produc-
tion of H2O2.. 9  It is predicted that in HIV/AIDS pa-
tients living with good oral hygiene, the lower Sali-
vary peroxidase activity.  
   In this study, patients with CD4> 500 cell/ µl have 
lower salivary peroxidase activity than patients with 
CD4+ < 500 sel/ µl, but that is only the trend of the 
research. The result showed that there was no signi-
ficant correlation between salivary peroxidase acti-
vity and the CD4+count in HIV/AIDS patients. Ba-
sed on the result of the clinical examination, patients 
with CD4+> 500 cell/ µl, have better oral hygiene 
than patients with low CD4+ count. Based on level 
of education, patients with CD4+>500cell/µl have a 
higher level of education and better job than patients 
with lower CD4+ count. Thus, HIV/AIDS patients 
with CD4+>500cell/ µl estimated to have awareness 
to maintain better oral health.  
   Linetal stated in their study, salivary flow rate was 
decreased in early stages of HIV infections. Salivary 
composition was altered as well. 8,10,15 In our study, 
patients with salivary flow rate >0.2 ml/minute are 
more than patients with Salivary flow rate <0.2 
ml/minute. This is probably because the number of 
samples is much less, and no data when patients 
were detected with HIV/AIDS. In our study, the  
relationship  between  salivary  flow  rate  and  pero- 
xidase activity, described the tendency of increasing 
peroxidase activity in salivary flow rate <0.2 
ml/minute.8 In hypofunction of salivary gland, 
which is salivary flow rate is less than normal, it is 
allowing the occurance of opportunistic infections is 
greater than normal salivary flow rate (>0,2ml/-
minute). The growth of micro organism increased 
the H2O2 level, and as one of the most important 
functions of Salivary peroxidase is the control of 
oral micro organisms thus it is predicted, in hypo-
salivation, the peroxidase activity increased. In this 
result study, the salivary peroxidase activity was 
trend to be increased in lower salivary flow rate. It 
can be concluded that salivary peroxidase activity 
might have a correlation with the total salivary 
protein concetration. There was tendency of higher 
total protein concentration and salivary peroxidase 
activity found in patients with lower CD4 counts but 
in those with more acidic saliva.  
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